Pfizer Ltd: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyTadworthNationwide (UK)Main market: Pharmaceutical products

Official UK PPONPCQW-3224-CMTGCompanies House00526209 ↗ · Active

Where they win
i

184 awards (180 for a named lot, 98%, 4 for a whole procedure with no lot named) · top CPV classes, shares of all 184 awards. An award may cover more than one class.

3360 Pharmaceutical products170 awards · 92% · 167 awards naming a lot + 3 whole-procedure awards
3369 Various medicinal products2 awards · 1% · awards naming a lot
3314 Medical consumables1 award · 1% · whole-procedure awards
Attributable award value
i
£36mOn 22 of 184 award records; the five largest make 91%. Largest rows below.
Typical attributable award
i
£48k middle valuerobust · n=22

Where their buyers are
i

ITL1 region of the buyer office · known for 113 of 113 awarded procedures · each procedure counts once

Greater London49 procedures · 43%
Scotland32 procedures · 28%
Wales (Cymru)18 procedures · 16%
North West England8 procedures · 7%
Northern Ireland4 procedures · 4%
South West England2 procedures · 2%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 10 notices name this supplier, covering 14 lots since 4 Sept 2025 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
12 of 14Lots on 10 notices: a place is won per lot.
Authorities bid for
i
1

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health89%(164 awards)
    164 of 184 awards are NHS & health (89%).
  • Type not classified10%(18 awards)
    18 of 184 awards are Type not classified (10%).
  • Central government1%(1 award)
    1 of 184 awards is Central government (1%).
  • Private contractor1%(1 award)
    1 of 184 awards is Private contractor (1%).

Share = of the 113 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

148 of 187 awards carry an end date, 57 estimated from the duration · not a retender forecast

ContractEndsPublished value
Lot 3 - Gonadotrophin Releasing Hormone - GNRH Agonists30 Nov 2026 estimated£285,555 ceiling
Range Generic & Biosimilar Cancer Medicines (unranked)3 Jan 2027 estimated£1,714,852 ceiling
Idarubicin Hydrochloride Solution For Infusion Vials3 Jan 2027 estimated£26,994 ceiling
Range of Generic Cancer Medicines (single supplier)3 Jan 2027 estimated£3,432,063 ceiling
Cisplatin Injections3 Jan 2027 estimated£266,998 ceiling
Etanercept19 Jan 2027 estimated£1,700,000 ceiling
Generic Drugs - Tablets & Capsules31 Jan 2027£8,611
Generic Anti-Infective Drugs31 Jan 2027£14,277
Wave 15a - Hospital Only Products (DNW & DLN regions)31 Jan 2027£1 ceiling
Hospital Only Products31 Jan 2027£1 ceiling

Soonest 10 of 36.

Recent awards

Latest 30 of 184 award records naming this supplier

Contracts Finder adds 3 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

Award / procedureAuthorityAwardedPublished value
Oral Contraceptive TabletsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£348,152 †
framework ceiling · 1 of 5 appointed suppliers
Contraceptives InjectionsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£328,826 †
framework ceiling · not attributable revenue
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026NHS EnglandNot published£665,389,588 †
framework ceiling · 1 of 24 appointed suppliers
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026NHS EnglandNot published£813,863,584 †
framework ceiling · 1 of 25 appointed suppliers
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£280,885 †
dynamic market estimate · not attributable revenue
IBSA PHARMA LIMITEDRegional Business Services Organisation Procurement and Logistics ServiceNot published£197,506 †
dynamic market estimate · not attributable revenue
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£83,749 †
dynamic market estimate · not attributable revenue
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£613,631 †
dynamic market estimate · not attributable revenue
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£2,585,753 †
dynamic market estimate · not attributable revenue
Generic, Branded Generic & Proprietary Medicinal Products - Group 18Regional Business Services Organisation Procurement and Logistics ServiceNot published£977,459 †
dynamic market estimate · not attributable revenue
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 91 of 187 awards, estimated from the published duration on 57 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.